US Patent Issued to Max-Planck-Gesellschaft zur Forderung der Wissenschaften on Sept. 23 for "Compounds for treatment of diseases and methods of screening therefor" (German, British Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,422,427, issued on Sept. 23, was assigned to Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. (Munich).

"Compounds for treatment of diseases and methods of screening therefor" was invented by Anthony A. Hyman (Dresden, Germany), Richard J. Wheeler (Oxford, Great Britain) and Marc Bickle (Dresden, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention related to a compound for use in prevention or treatment of a neurodegenerative disease associated with the formation of stress granules. The compound is selected from lipoic acid, lipoamide, dihydrolipoic acid, and dihydrolipoamide. The invention further relates to a met...